Predicting the response to air travel in passengers with non-obstructive lung disease: are the current guidelines appropriate?

Authors:
Address: Respiratory Physiology Laboratory, Christchurch Hospital, Christchurch, New Zealand. paul.kelly@cdhb.govt.nz
Journal:


Publication:

abstract

BACKGROUND AND OBJECTIVE:

air travel guidelines recommend using baseline arterial oxygen levels and the hypoxic challenge test (HCT) to predict in-flight hypoxaemia and the requirement for in-flight oxygen in patients with lung disease. The purpose of the present study was to (i) quantify the hypoxaemic response to air travel and (ii) identify baseline correlate(s) to predict this response in passengers with non-obstructed lung disease.

METHODS:

Fourteen passengers (seven women) with chronic non-obstructed lung disease volunteered for this study. The study involved three phases: (i) respiratory function testing; (ii) in-flight measures (SpO(2), cabin pressure and dyspnoea); and (iii) a HCT. The in-flight hypoxaemic response was compared with the baseline arterial oxygen level, respiratory function and the HCT.

RESULTS:

All subjects flew without oxygen and no adverse events were recorded in-flight. Mean cabin pressure was 593 +/- 16 mm Hg. Pre-flight SpO(2) was 95 +/- 3% and significantly decreased to 85 +/- 9% in-flight, with further significant falls in subjects who walked during the flight (nadir SpO(2) 78 +/- 11%). The pre-flight SpO(2) showed the strongest correlation with in-flight SpO(2) (r = 0.91, P < 0.001). The HCT SpO(2) was moderately correlated to the in-flight SpO(2) (r = 0.58, P < 0.05). Spirometry, D(L,CO) and TLC measurements did not correlate with in-flight SpO(2).

CONCLUSION:

Significant in-flight desaturation can be expected in passengers with non-obstructive lung disease. Respiratory function did not predict in-flight desaturation. We found a good relationship between pre-flight SpO(2) and in-flight SpO(2) which supports the role of pre-flight oximetry for Predicting in-flight hypoxaemia in passengers with non-obstructed lung disease.



Related Articles
Air travel hypoxemia vs. the hypoxia inhalation test in passengers with COPD.
Chest. 2008
Air travel hypoxemia vs. the hypoxia inhalation test in passengers with COPD.
Kelly PT, Swanney MP, Seccombe LM, Frampton C, Peters MJ, Beckert L. Chest. 2008 Apr; 133(4):920-6. Epub 2007 Nov 7.
Normobaric hypoxia inhalation test vs. response to airline flight in healthy passengers.
Aviat Space Environ Med. 2006
Normobaric hypoxia inhalation test vs. response to airline flight in healthy passengers.
Kelly PT, Swanney MP, Frampton C, Seccombe LM, Peters MJ, Beckert LE. Aviat Space Environ Med. 2006 Nov; 77(11):1143-7.
Predicting hypoxaemia during flights in children with cystic fibrosis.
Thorax. 2001
Predicting hypoxaemia during flights in children with cystic fibrosis.
Buchdahl RM, Babiker A, Bush A, Cramer D. Thorax. 2001 Nov; 56(11):877-9.
Review Hypoxia during air travel in adults with pulmonary disease.
Am J Med Sci. 2008
Review Hypoxia during air travel in adults with pulmonary disease.
Mohr LC. Am J Med Sci. 2008 Jan; 335(1):71-9.
Review Hypoxia altitude simulation test.
Chest. 2008
Review Hypoxia altitude simulation test.
Dine CJ, Kreider ME. Chest. 2008 Apr; 133(4):1002-5.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.